134 related articles for article (PubMed ID: 10906769)
1. Performance evaluation of a new chemiluminescent assay for prostate specific antigen.
Dasgupta A; Wells A; Datta P
J Clin Lab Anal; 2000; 14(4):164-8. PubMed ID: 10906769
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of a new chemiluminescent cardiac troponin I assay.
Dasgupta A; Chow L; Nazareno L; Tso G; Datta P
J Clin Lab Anal; 2000; 14(5):224-9. PubMed ID: 11018801
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an automated chemiluminescent immunoassay for complexed PSA on the Bayer ACS:180 system.
Datta P; Dasgupta A
J Clin Lab Anal; 2003; 17(5):174-8. PubMed ID: 12938146
[TBL] [Abstract][Full Text] [Related]
4. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
Vessella RL; Noteboom J; Lange PH
Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
[TBL] [Abstract][Full Text] [Related]
6. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer.
Mitchell ID; Croal BL; Dickie A; Cohen NP; Ross I
J Urol; 2001 May; 165(5):1549-53. PubMed ID: 11342915
[TBL] [Abstract][Full Text] [Related]
7. New developments in the standardization of total prostate-specific antigen.
Blijenberg BG; Storm BN; Van Zelst BD; Kruger AE; Schröder FH
Clin Biochem; 1999 Nov; 32(8):627-34. PubMed ID: 10638945
[TBL] [Abstract][Full Text] [Related]
8. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.
Leewansangtong S; Goktas S; Lepoff R; Holthaus K; Crawford ED
Urology; 1998 Sep; 52(3):467-9. PubMed ID: 9730462
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance evaluation of a new turbidimetric immunoassay for valproic acid on the ADVIA 1650 analyzer: effect of gross hemolysis and high bilirubin.
Datta P; Dasgupta A
J Clin Lab Anal; 2005; 19(2):31-5. PubMed ID: 15756706
[TBL] [Abstract][Full Text] [Related]
10. A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.
Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
Clin Chem Lab Med; 2003 Jan; 41(1):90-4. PubMed ID: 12636056
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 3 investigational assays for the free form of prostate specific antigen.
Nixon RG; Meyer GE; Blase AB; Gold MH; Brawer MK
J Urol; 1998 Aug; 160(2):420-5. PubMed ID: 9679890
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of assays for prostate-specific antigen molecular forms.
Kuriyama M; Uno H; Ueno K; Hamamoto Y; Vihn PQ; Ban Y
Jpn J Clin Oncol; 1999 Jun; 29(6):303-7. PubMed ID: 10418560
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
[TBL] [Abstract][Full Text] [Related]
14. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
[TBL] [Abstract][Full Text] [Related]
15. Analytical performance of a new chemiluminescent phenytoin (ACS:180) assay.
Dasgupta A; Datta P; Redlich G; Limmany A
Ther Drug Monit; 1997 Apr; 19(2):191-4. PubMed ID: 9108649
[TBL] [Abstract][Full Text] [Related]
16. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
[TBL] [Abstract][Full Text] [Related]
17. Analytic performance evaluation of a new turbidimetric immunoassay for carbamazepine on the ADVIA 1650 analyzer: effect of carbamazepine 10,11-epoxide.
Dasgupta A; Datta P
Ther Drug Monit; 2005 Feb; 27(1):31-4. PubMed ID: 15665743
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
[TBL] [Abstract][Full Text] [Related]
19. Negative interference of bilirubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK-MB assay.
Dasgupta A; Wells A; Biddle DA
J Clin Lab Anal; 2001; 15(2):76-80. PubMed ID: 11291109
[TBL] [Abstract][Full Text] [Related]
20. Determination of non-alpha1-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnostic accuracy.
Wesseling S; Stephan C; Semjonow A; Lein M; Brux B; Sinha P; Loening SA; Jung K
Clin Chem; 2003 Jun; 49(6 Pt 1):887-94. PubMed ID: 12765984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
